Allmed Medical Products Co Ltd

Chart & Performance

D1W1MN

P/E

47.29

P/S

1.89

EPS

0.18

Div Yield, %

1.25%

Shrs. gr., 5y

2.45%

Rev. gr., 5y

6.34%

Revenues

2.76b

-34.53%

Net income

110m

-72.86%

CFO

426m

-62.92%

Dividend

Jun 19, 20240.027051 CNY/sh

Earnings

May 23, 2025

Profile

Allmed Medical Products Co., Ltd engages in the manufacture and sale of wound care and nursing material products in China. The company's general wound care products include elastic and adhesive bandage, oil emulsion, xeroform gauze, woven gauze swabs, fluffy bandages/sponges, abdominal pads, gauze/non-woven drain sponges, post-op sponges, eye pads, cotton filled exodontia sponges, non-stick pads, and petrolatum gauze dressing. It also provides OR/surgery products, including X-ray non-woven swabs, OR towels, laparotomy and neuro sponges, X-ray gauze swabs, and X-ray detectable gauze balls and nonwoven balls; various kits; and patient care products comprising disposable nursing pads and disposable drapes. The company also exports its products. Allmed Medical Products Co., Ltd was founded in 1992 and is based in Shenzhen, the People's Republic of China.

URL

http://cn.allmed-china.com/

IPO date

Mar 11, 2019

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title CNY in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title CNY in thousands, except ratios and share amounts	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12	2015‑12
Income
Revenues	2,756,665 -34.53%	4,210,503 43.92%
Cost of revenue	2,269,049	3,084,019
Unusual Expense (Income)
NOPBT	487,616	1,126,483
NOPBT Margin	17.69%	26.75%
Operating Taxes	64,825	80,256
Tax Rate	13.29%	7.12%
NOPAT	422,791	1,046,228
Net income	110,400 -72.86%	406,792 -5.66%
Dividends	(65,212)	(132,986)
Dividend yield	1.09%	1.71%
Proceeds from repurchase of equity
BB yield
Debt
Debt current	749,573	821,344
Long-term debt	155,536	111,488
Deferred revenue	191,937	189,682
Other long-term liabilities	197,258	5,334
Net debt	(540,342)	(464,567)
Cash flow
Cash from operating activities	426,301	1,149,728
CAPEX	(286,481)
Cash from investing activities	(218,254)
Cash from financing activities	(328,809)
FCF	105,786	1,342,941
Balance
Cash	493,859	786,836
Long term investments	951,592	610,562
Excess cash	1,307,618	1,186,874
Stockholders' equity	2,659,698	2,579,722
Invested Capital	3,001,099	3,056,509
ROIC	13.96%	34.59%
ROCE	10.82%	25.11%
EV
Common stock shares outstanding	633,390	633,265
Price	9.48 -22.61%	12.25 -25.08%
Market cap	6,004,537 -22.60%	7,757,501 -25.08%
EV	5,487,925	7,322,848
EBITDA	714,995	1,319,682
EV/EBITDA	7.68	5.55
Interest	33,199	35,471
Interest/NOPBT	6.81%	3.15%